Research Site — Curitiba

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

369

Registered studies

177

Active

Recruiting now

156

Completed

Stopped or withdrawn

Most-studied conditions

Relapsed/Refractory Follicular Lymphoma · Cervical Cancer · Diffuse Large B-Cell Lymphoma · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or…

Recently updated registry entries

NCT07175428 — Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation (Recruiting)
NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)
NCT03521154 — A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.